Research Site — Concord, North Carolina

Research Site is a clinical research site located in Concord, North Carolina, United States 28025.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Research Site has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Relapsing Multiple Sclerosis, Peripheral Artery Disease, Non-Small Cell Lung Cancer.

Sponsors: Biogen, AstraZeneca, Amgen.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 8 clinical trials on record, with 1 currently active. Their work covers Relapsing Multiple Sclerosis, Peripheral Artery Disease, Non-Small Cell Lung Cancer.

Is Research Site accredited by Crixeo Health?

Yes — Research Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.